2. Kim KM, Kim YM, Shim YS, Kim KH, Chang HS, Choi JO, et al. Epidemiologic survey of head and neck cancers in Korea. J Korean Med Sci 2003;18:80-87. PMID:
12589092.
3. Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 1998;18:4779-4786. PMID:
9891557.
4. Fountzilas G, Tolis C, Kalogera-Fountzila A, Karanikiotis C, Bai M, Misailidou D, et al. Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma: a Hellenic Cooperative Oncology Group phase II study. Strahlenther Onkol 2005;181:223-230. PMID:
15827691.
5. Lin S, Tham IW, Pan J, Han L, Chen Q, Lu JJ. Combined high-dose radiation therapy and systemic chemotherapy improves survival in patients with newly diagnosed metastatic nasopharyngeal cancer. Am J Clin Oncol 2012;35:474-479. PMID:
21577086.
6. Lovell SJ, Wong HB, Loh KS, Ngo RY, Wilson JA. Impact of dysphagia on quality-of-life in nasopharyngeal carcinoma. Head Neck 2005;27:864-872. PMID:
16114007.
7. Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, Karlsson U, et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005;61:772-778. PMID:
15708256.
8. Garcia-Peris P, Paron L, Velasco C, de la Cuerda C, Camblor M, Breton I, et al. Long-term prevalence of oropharyngeal dysphagia in head and neck cancer patients: impact on quality of life. Clin Nutr 2007;26:710-717. PMID:
17954003.
9. McHorney CA, Bricker DE, Kramer AE, Rosenbek JC, Robbins J, Chignell KA, et al. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development. Dysphagia 2000;15:115-121. PMID:
10839823.
10. Woisard V, Andrieux MP, Puech M. Validation of a self-assessment questionnaire for swallowing disorders (Deglutition Handicap Index). Rev Laryngol Otol Rhinol (Bord) 2006;127:315-325. PMID:
17425006.
11. Belafsky PC, Mouadeb DA, Rees CJ, Pryor JC, Postma GN, Allen J, et al. Validity and reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol 2008;117:919-924. PMID:
19140539.
12. Chen AY, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001;127:870-876. PMID:
11448365.
13. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 2005;8:94-104. PMID:
15804318.
14. Lee Y, Kim E, Oh SJ, Lee BS, Kim DA. The linguistic validation and reliability of the Korean version 'Qualiveen Questionnaire'. J Korean Acad Rehabil Med 2010;34:524-543.
15. Collins MM, O'Leary MP, Calhoun EA, Pontari MA, Adler A, Eremenco S, et al. The Spanish National Institutes of Health-Chronic Prostatitis Symptom Index: translation and linguistic validation. J Urol 2001;166:1800-1803. PMID:
11586227.
16. Oh SJ, Park HG, Paick SH, Park WH, Choo MS. Translation and linguistic validation of Korean version of the King's Health Questionnaire Instrument. Korean J Urol 2005;46:438-450.
17. Homma Y, Tsukamoto T, Yasuda K, Ozono S, Yoshida M, Shinji M. Linguistic validation of Japanese version of International Prostate Symptom Score and BPH impact index. Nihon Hinyokika Gakkai Zasshi 2002;93:669-680. PMID:
12385091.
18. Quittner AL, Sweeny S, Watrous M, Munzenberger P, Bearss K, Gibson Nitza A, et al. Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. J Pediatr Psychol 2000;25:403-414. PMID:
10980045.
19. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417-1432. PMID:
8263569.
20. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000;25:3186-3191. PMID:
11124735.
21. American Speech-Language-Hearing Association. Adult Speech-Language pathology training manual. National Outcomes Measurement System (NOMS). Rockville: American Speech-Language-Hearing Association; 1998.
22. CronbacH LJ, Meehl PE. Construct validity in psychological tests. Psychol Bull 1955;52:281-302. PMID:
13245896.
23. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 4th ed. New York: Oxford University Press; 2008.
24. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-428. PMID:
18839484.
25. Low J, Wyles C, Wilkinson T, Sainsbury R. The effect of compliance on clinical outcomes for patients with dysphagia on videofluoroscopy. Dysphagia 2001;16:123-127. PMID:
11305222.
26. Rosenvinge SK, Starke ID. Improving care for patients with dysphagia. Age Ageing 2005;34:587-593. PMID:
16267184.
27. Crawford H, Leslie P, Drinnan MJ. Compliance with dysphagia recommendations by carers of adults with intellectual impairment. Dysphagia 2007;22:326-334. PMID:
17701245.
28. List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer 1990;66:564-569. PMID:
2364368.
29. Lin BM, Starmer HM, Gourin CG. The relationship between depressive symptoms, quality of life, and swallowing function in head and neck cancer patients 1 year after definitive therapy. Laryngoscope 2012;122:1518-1525. PMID:
22467530.
30. de Leeuw JR, de Graeff A, Ros WJ, Blijham GH, Hordijk GJ, Winnubst JA. Prediction of depressive symptomatology after treatment of head and neck cancer: the influence of pre-treatment physical and depressive symptoms, coping, and social support. Head Neck 2000;22:799-807. PMID:
11084641.
31. Speyer R, Heijnen BJ, Baijens LW, Vrijenhoef FH, Otters EF, Roodenburg N, et al. Quality of life in oncological patients with oropharyngeal dysphagia: validity and reliability of the Dutch version of the MD Anderson Dysphagia Inventory and the Deglutition Handicap Index. Dysphagia 2011;26:407-414. PMID:
21279522.
32. Carlsson S, Ryden A, Rudberg I, Bove M, Bergquist H, Finizia C. Validation of the Swedish M. D. Anderson Dysphagia Inventory (MDADI) in patients with head and neck cancer and neurologic swallowing disturbances. Dysphagia 2012;27:361-369. PMID:
22105944.
33. Guedes RL, Angelis EC, Chen AY, Kowalski LP, Vartanian JG. Validation and application of the M.D. Anderson Dysphagia Inventory in patients treated for head and neck cancer in Brazil. Dysphagia 2013;28:24-32. PMID:
22684923.
34. Chen PH, Golub JS, Hapner ER, Johns MM 3rd. Prevalence of perceived dysphagia and quality-of-life impairment in a geriatric population. Dysphagia 2009;24:1-6. PMID:
18368451.